Of the 62,000 people diagnosed with pancreatic cancer this year, it's estimated nearly 50,000 will die. It's long been known as a death sentence diagnosis. But there is hope in medical advances. In this episode I talk with Jordan M. Winter, MD. A nationally recognized, board-certified surgeon with a special interest in the medical and surgical management of pancreatic and related cancers, pancreatic cysts, chronic pancreatitis, bile duct strictures, biliary, gastric and liver cancers and abdominal tumors.
In addition to being a highly skilled clinician, Dr. Winter is a leader in translational and basic research. As director of the Winter Lab, which is funded by the American Cancer Society and the NIH, he is at the forefront of investigational efforts to find alternative treatments for pancreatic cancer. The lab seeks to understand how pancreatic cancer cells survive in their microenvironment and identify their metabolic weaknesses to ultimately discover new and effective therapies. A clinical study will soon be underway to study the use of a novel metabolic inhibitor.
His titles include:
Member, GI Cancer Genetics Program, Case Comprehensive Cancer Center
